/

Merida Biosciences

Developing precision therapeutics for autoimmune and allergic diseases.

BiotechnologyPharmaceuticals meridabio.com ↗

Company facts

Founded: 2022
Employees: 50
Headquarters: United States
Type: Private
Funding: Series A · $121M · 2025